Dosing underway in Rain Therapeutics' mid-stage milademetan trial for advanced solid tumors
November 19 2021 - 8:40AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Rain Oncology (NASDAQ:RAIN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rain Oncology (NASDAQ:RAIN)
Historical Stock Chart
From Apr 2023 to Apr 2024